Subjects on non-calcium or aluminum containing phosphate binders (example: sevelamer HCl, lanthanum) 30 days prior to screening.

Subjects on cinacalcet 30 days prior to screening.

Current or previous use of some osteoporosis medications.

Started or required change in cholesterol lowering medications within 30 days before screening.

Abnormal rhythm of the heart.

Parathyroidectomy done within 3 months prior to screening.

Anticipated parathyroidectomy or kidney transplant.

Current intolerance to oral medications, or inability to swallow.

Unstable medical condition.

Currently enrolled, or fewer than 30 days have passed since subject used another investigational device or drug.

Pregnancy or breast feeding.

ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis